Literature DB >> 2572719

Type 1 fimbriate strains of Escherichia coli initiate renal parenchymal scarring.

N Topley1, R Steadman, R Mackenzie, J M Knowlden, J D Williams.   

Abstract

The renal scarring which characterizes chronic pyelonephritis is initiated by bacterial infection and is independent on the activation of an inflammatory response. Although the presence of polymorphonuclear leukocytes (PMN) is essential for initiating the scarring process, the bacterial structures responsible for their activation have not been investigated. In an animal model of chronic pyelonephritis the surface area of the renal scars produced by Type 1 fimbriate escherichia coli (E. coli) was significantly greater than that of those produced by P fimbriate and non-fimbriate strains (P less than 0.01). The activation of human PMN by the same Type 1 fimbriate organisms resulted in a significant release of lysosomal neutral protease activity (P less than 0.001) and activation of the respiratory burst (P less than 0.01). The neutral protease release in response to P fimbriate and non-fimbriate organisms was not significantly increased. The extent of renal scarring also correlated with the release of neutral protease activity (P less than 0.02) and with the degree of activation of the respiratory burst (P less than 0.05). These results demonstrate that the ability of E. coli strains to cause renal scars may be related to their capacity to express Type 1 fimbria, which may be a causative factor in the in vivo activation of the inflammatory response.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2572719     DOI: 10.1038/ki.1989.237

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  7 in total

Review 1.  Reactive oxygen molecules, oxidant injury and renal disease.

Authors:  S P Andreoli
Journal:  Pediatr Nephrol       Date:  1991-11       Impact factor: 3.714

Review 2.  Applications from bacterial adhesion and biofilm studies in relation to urogenital tissues and biomaterials: a review.

Authors:  G Reid
Journal:  J Ind Microbiol       Date:  1994-03

Review 3.  Virulence factors in Escherichia coli urinary tract infection.

Authors:  J R Johnson
Journal:  Clin Microbiol Rev       Date:  1991-01       Impact factor: 26.132

4.  The selective augmentation by recombinant human tumour necrosis factor-alpha of neutrophil responses to pathogenic Escherichia coli.

Authors:  R Steadman; M M Petersen; D Williams; N Matthews; J D Williams
Journal:  Immunology       Date:  1990-05       Impact factor: 7.397

5.  Nonlethal adherence to human neutrophils mediated by Dr antigen-specific adhesins of Escherichia coli.

Authors:  J R Johnson; K M Skubitz; B J Nowicki; K Jacques-Palaz; R M Rakita
Journal:  Infect Immun       Date:  1995-01       Impact factor: 3.441

6.  Extracellular release of reactive oxygen species from human neutrophils upon interaction with Escherichia coli strains causing renal scarring.

Authors:  H Mundi; B Björkstén; C Svanborg; L Ohman; C Dahlgren
Journal:  Infect Immun       Date:  1991-11       Impact factor: 3.441

7.  The possible role of granulocyte elastase in renal damage from acute pyelonephritis.

Authors:  M Monga; J A Roberts
Journal:  Pediatr Nephrol       Date:  1995-10       Impact factor: 3.714

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.